10 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
ASCVD or ASCVD risk ... ASCVD or ASCVD risk ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM
Child Sex Trafficking Screening Tool

Source Article:

Evaluation of a Screening Tool for Child Sex Trafficking Among Patients
Patients With High‐Risk ... doi/full/10.1111/acem ... Screening #Tool #Peds
Validation of the “Step-by-Step” Approach in the Management of Young Febrile Infants
Visual Abstract by Dr. Kirsty
pubmed/27382134 #EBM ... #Peds #Pediatrics ... Febrile #Infant #Risk
PocketPEM - BRUE - Brief Resolved Unexplained Events #Diagnosis #Management #Peds #EM #BRUE #Risk #PocketCard #PocketPEM
Diagnosis #Management #Peds ... #EM #BRUE #Risk
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

CONCLUSIONS:
Among patients with heart failure and a
fraction, the risk ... Dapagliflozin #hfref ... visualabstract #ebm
Decision Aid - What is the risk of serious infection in febrile infants (<60 days old)?

Reference:
- What is the risk ... Febrile #Infant #Peds ... #Stewardship #EBM ... Serious #Infection #Risk
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Preoperative Risk ... any modifiable risk ... perioperative risk ... Cataract Plan for Meds ... ACEi/ARBs - Hold
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Risk Factors and ... • Avoid ARB/ACE-I ... Risk of recurrence ... teratogenic GDMT meds ... (e.g., ACE/ARB)
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
conditions, RAAS meds ... ACE inhibitors, ... they carry the risk
The Febrile Infant Step-by-Step Algorithm
This is an algorithm developed by European emergency physicians to identify low-risk
to identify low-risk ... 46.9% #Diagnosis #EBM ... Management #Pediatrics #Peds ... #Antibiotics #Risk